Posted inGeneral Surgery news Oncology
Tailoring Prognostication in Pancreatic Ductal Adenocarcinoma: Impact of Neoadjuvant Therapy on Survival Predictors
Neoadjuvant therapy alters key prognostic factors in resected pancreatic ductal adenocarcinoma, enabling personalized survival prediction models distinct from chemo-naïve patients.


















